Tag: R d costs

Over 90% of drug candidates that enter the clinical trial stage fail to reach the market, highlighting the immense difficulty in getting FDA approval. This staggering statistic underscores the complex and high-risk nature of pharmaceutical research and development, a process fraught with challenges at every turn.

A 2024 study in *JAMA* estimated the median cost of bringing a new drug to market at nearly $1 billion, and for biologic drugs like Bimzelx, this figure can be even higher, contributing significantly to its expensive price. The high price tag of specialized medications is a significant barrier for many patients, prompting the question, 'Why is Bimzelx so expensive?'